PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 19920668-6 1995 In the presence of Ringer"s lactate plus bovine serum albumin or mock aqueous solution, the influence of surface tension of the 100,000-MW hyaluronic acid was moderated: with lower hyaluronic acid concentrations, the decline in surface tension was more than with Ringer"s lactate, but with higher hyaluronic acid concentrations, the decline in surface tension was less than with Ringer"s lactate. Hyaluronic Acid 139-154 albumin Homo sapiens 48-61 19920668-6 1995 In the presence of Ringer"s lactate plus bovine serum albumin or mock aqueous solution, the influence of surface tension of the 100,000-MW hyaluronic acid was moderated: with lower hyaluronic acid concentrations, the decline in surface tension was more than with Ringer"s lactate, but with higher hyaluronic acid concentrations, the decline in surface tension was less than with Ringer"s lactate. Hyaluronic Acid 181-196 albumin Homo sapiens 48-61 19920668-6 1995 In the presence of Ringer"s lactate plus bovine serum albumin or mock aqueous solution, the influence of surface tension of the 100,000-MW hyaluronic acid was moderated: with lower hyaluronic acid concentrations, the decline in surface tension was more than with Ringer"s lactate, but with higher hyaluronic acid concentrations, the decline in surface tension was less than with Ringer"s lactate. Hyaluronic Acid 181-196 albumin Homo sapiens 48-61 33236916-1 2020 The assembly-disassembly of hyaluronic acid (HA) with a bovine serum albumin-conjugated gold nanoparticle (BSA-AuNP) was demonstrated using a gas-phase electrophoresis approach, electrospray-differential mobility analysis (ES-DMA). Hyaluronic Acid 28-43 albumin Homo sapiens 63-76 33236916-1 2020 The assembly-disassembly of hyaluronic acid (HA) with a bovine serum albumin-conjugated gold nanoparticle (BSA-AuNP) was demonstrated using a gas-phase electrophoresis approach, electrospray-differential mobility analysis (ES-DMA). Hyaluronic Acid 45-47 albumin Homo sapiens 63-76 34056317-6 2021 X-ray photoelectron spectroscopy results suggest that the hydrogel molecule rearranges so that polyethylene glycol is pointing up toward the surface while hyaluronic acid folds to interact with bovine serum albumin of the nanoparticles. Hyaluronic Acid 155-170 albumin Homo sapiens 201-214 34752986-2 2022 In this study we evaluated the potential of an indocyanine green (ICG) and paclitaxel (PTX) loaded human serum albumin (HSA) nanoparticles that was conjugated with hyaluronic acid for use in image-guided drug delivery targeted to CD44-positive non-small cell lung cancer (NSCLC). Hyaluronic Acid 164-179 albumin Homo sapiens 105-118 34823812-2 2022 Herein, based on the discovery of unique cisplatin-hydrazide and cisplatin-indocyanine green (ICG) coordination reactions, a multifunctional coordination nanoprodrug, cisplatin/ICG co-loaded hydrazided hyaluronan/bovine serum albumin (HBCI) nanoparticles, was developed by a desolvation-dual coordination process. Hyaluronic Acid 202-212 albumin Homo sapiens 220-233 34830249-0 2021 Albumin-Hyaluronan Interactions: Influence of Ionic Composition Probed by Molecular Dynamics. Hyaluronic Acid 8-18 albumin Homo sapiens 0-7 34830249-6 2021 In the context of synovial fluid, it is relevant to describe the possible interactions between albumin and hyaluronate, taking into account solution composition effects. Hyaluronic Acid 107-118 albumin Homo sapiens 95-102 34830249-8 2021 It was established that the presence of divalent cations, and especially Ca2+, contributes mostly to the increase of the affinity between hyaluronan and albumin, which is associated with charge compensation in negatively charged hyaluronan and albumin. Hyaluronic Acid 138-148 albumin Homo sapiens 153-160 34830249-8 2021 It was established that the presence of divalent cations, and especially Ca2+, contributes mostly to the increase of the affinity between hyaluronan and albumin, which is associated with charge compensation in negatively charged hyaluronan and albumin. Hyaluronic Acid 138-148 albumin Homo sapiens 244-251 34181997-0 2021 Therapeutic contact lenses fabricated by hyaluronic acid and silver incorporated bovine serum albumin porous films for the treatment of alkali-burned corneal wound. Hyaluronic Acid 41-56 albumin Homo sapiens 88-101 34181997-1 2021 Hyaluronic acid (HA) was covalently linked to the surface of bovine serum albumin/silver (BSA/Ag) porous films to fabricate a possible contact lens. Hyaluronic Acid 0-15 albumin Homo sapiens 68-81 34181997-1 2021 Hyaluronic acid (HA) was covalently linked to the surface of bovine serum albumin/silver (BSA/Ag) porous films to fabricate a possible contact lens. Hyaluronic Acid 17-19 albumin Homo sapiens 68-81 35219153-4 2022 Interfacial interaction of albumins and hyaluronic acid reveals that human albumin presents limited conformational changes upon adsorption, which increase by complexation with the polysaccharide present at the interface. Hyaluronic Acid 40-55 albumin Homo sapiens 75-82 35219153-6 2022 The interfacial unfolding induced in human albumin by hyaluronic acid facilitates in vitro lipolysis while its limited conformational changes provide the largest protection against in vitro lipolysis. Hyaluronic Acid 54-69 albumin Homo sapiens 43-50 33652648-3 2021 In this work, redox-responsive micelle-like nanoparticles were prepared by self-assembling of a hyaluronic acid-human serum albumin conjugate containing cystamine moieties acting as a functional spacer. Hyaluronic Acid 96-111 albumin Homo sapiens 118-131 33838186-4 2021 For this, firstly hyaluronic acid modified magnetic nanoparticles cross-linked enzyme fine aggregates of isocitrate dehydrogenases (IDH/HA/MNPs-CLEAs) were synthesized, and secondly bovine serum albumin (BSA) as co-feeder was used to synthesize the IDH/BSA/HA/MNPs-CLEAs. Hyaluronic Acid 18-33 albumin Homo sapiens 189-202 33142605-2 2021 To the best of our knowledge, this article is the first which summarizes in detail the pH-dependent quantitative relationship between the bovine serum albumin (BSA) and hyaluronic acid (HyA) confirmed by several physico-chemical techniques. Hyaluronic Acid 169-184 albumin Homo sapiens 145-158 28992804-8 2017 Grafting hyaluronic acid to the poly(2-hydroxyethyl methacrylate) surfaces decreased the contact angle, the dehydration rate, and the amount of nonspecific sorption of lysozyme and albumin in comparison to pristine hydrogel materials, suggesting the development of more wettable surfaces with improved water-retentive and antifouling properties, while maintaining optical transparency (>92%). Hyaluronic Acid 9-24 albumin Homo sapiens 181-188 30893796-4 2019 Here, we prepared a hydrogel system based on methylcellulose (MC) and hyaluronic acid (HA), which possesses mucosal healing properties, incorporating a model macromolecular drug, namely (fluorescently-labeled) bovine serum albumin (BSA). Hyaluronic Acid 87-89 albumin Homo sapiens 217-230 28551526-2 2017 Specifically, the adsorption of human serum albumin on to polystyrene latex and to silica is described, focusing on how this is affected by hyaluronan. Hyaluronic Acid 140-150 albumin Homo sapiens 38-51 31541736-3 2019 In this study, efficient silencing of GFP expression by combining high N/P ratio siRNA and branched PEI (bPEI) polyplexes (siRNA-bPEI) polyplexes with glycosaminoglycans (GAGs), namely hyaluronic acid (HA), chondroitin sulfate (CS) and heparin sulfate (HS), and human serum albumin (HSA) is reported. Hyaluronic Acid 185-200 albumin Homo sapiens 268-281 30659529-6 2019 OBJECTIVE: In this article, our goal is to develop new targeting nanoparticles based on the conjugation of albumin and Hyaluronic Acid (HA) for pancreatic cancer cells. Hyaluronic Acid 136-138 albumin Homo sapiens 107-114 28212584-0 2017 Hyaluronic acid-serum albumin conjugate-based nanoparticles for targeted cancer therapy. Hyaluronic Acid 0-15 albumin Homo sapiens 16-29 24649886-1 2014 A novel transdermal hyaluronic acid (HA) conjugated with bovine serum albumin (BSA) was developed in the form of solid-in-oil (S/O) nanodispersion (129.7 nm mean diameter). Hyaluronic Acid 20-35 albumin Homo sapiens 64-77 24649886-1 2014 A novel transdermal hyaluronic acid (HA) conjugated with bovine serum albumin (BSA) was developed in the form of solid-in-oil (S/O) nanodispersion (129.7 nm mean diameter). Hyaluronic Acid 37-39 albumin Homo sapiens 64-77 24517623-1 2014 Selective coacervation with hyaluronic acid (HA), a biocompatible and injectable anionic polysaccharide, was used to isolate a target protein, bovine serum albumin (BSA), with 90% purity from a 1:1 mixture with a second protein of similar pI, beta-lactoglobulin (BLG). Hyaluronic Acid 28-43 albumin Homo sapiens 150-163 24517623-1 2014 Selective coacervation with hyaluronic acid (HA), a biocompatible and injectable anionic polysaccharide, was used to isolate a target protein, bovine serum albumin (BSA), with 90% purity from a 1:1 mixture with a second protein of similar pI, beta-lactoglobulin (BLG). Hyaluronic Acid 45-47 albumin Homo sapiens 150-163 20188528-0 2010 Electrodeposition of hyaluronic acid and hyaluronic acid-bovine serum albumin films from aqueous solutions. Hyaluronic Acid 41-56 albumin Homo sapiens 64-77 18758848-6 2008 The ratio of serum hyaluronic acid to the maximum removal rate of technetium-99 m diethylenetriaminepentaacetic acid galactosyl human serum albumin (hyaluronate/GSA-Rmax ratio) was calculated. Hyaluronic Acid 19-34 albumin Homo sapiens 134-147 18758848-6 2008 The ratio of serum hyaluronic acid to the maximum removal rate of technetium-99 m diethylenetriaminepentaacetic acid galactosyl human serum albumin (hyaluronate/GSA-Rmax ratio) was calculated. Hyaluronic Acid 149-160 albumin Homo sapiens 134-147